RxDoctor Payments Data

Mary Dimarsico, DO

Family Medicine · Versailles, MONPI 1013982818

Payments from drug & device makers

$840in general payments, 2019–2025

Across 46 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$204
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$110
  • AstraZeneca$70
  • Dexcom, Inc.$55
  • Sunovion Pharmaceuticals Inc.$52
  • Teva Pharmaceuticals USA, Inc.$49
  • plus $300 from 11 others

What the payments were for

  • Food & beverage$80496%
  • Education$364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$840 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$3,616
Medicare patients
90
Services billed
956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$36,912
JanuviaSitagliptin Phosphate29$24,785
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$22,887
RexultiBrexpiprazole11$15,605
FarxigaDapagliflozin Propanediol19$15,422
TrulicityDulaglutide13$12,586
XareltoRivaroxaban22$12,526
SymbicortBudesonide/Formoterol Fumarate29$9,560
Serevent DiskusSalmeterol Xinafoate21$9,195
Bevespi AerosphereGlycopyrrolate/Formoterol Fum16$6,787
Atrovent HfaIpratropium Bromide13$6,323
Tresiba Flextouch U-100Insulin Degludec15$5,346
Gabapentin227$3,534
Fluphenazine Hcl11$2,952
Albuterol Sulfate HfaAlbuterol Sulfate134$2,819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort, Bevespi Aerosphere$70$31,76964 claims
Otsuka America Pharmaceutical, Inc.Rexulti$30$15,60511 claims
Johnson & JohnsonXarelto$16$12,52622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Versailles

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →